Qureight Expands with Addition of Second Site, to Accommodate Rapid Growth and Ongoing Development of Chest Foundation Model
- Investment in new premises in London reflects significant milestone in Company’s growth, following $20 million Series B financing
- Supports rapid scale-up and development of foundational AI imaging model, to improve clinical trial design across broader range of chest diseases
